6076 Catalytic cysteine domain in ubiquitin-activating enzyme
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Mixed metal/non-metal compounds | 1 | 0.1 | 12× | not tested | |
| Nucleosides, nucleotides, and analogues | 3 | 1.1 | 2.75× | not tested | |
| Organic acids and derivatives | 1 | 0.6 | 1.64× | not tested | |
| Homogeneous non-metal compounds | 1 | 0.9 | 1.18× | not tested | |
| Homogeneous metal compounds | 2 | 1.9 | 1.03× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00171 | ATP | ATP | 12 |
| DB04119 | TBR | Hexatantalum Dodecabromide | 4 |
| DB00172 | PRO | Proline | 2 |
| DB04216 | — | Quercetin | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CL | CHLORIDE ION | 8 |
| ATP | ADENOSINE-5'-TRIPHOSPHATE | 4 |
| TBR | HEXATANTALUM DODECABROMIDE | 3 |
| PRO | PROLINE | 2 |
| AMP | ADENOSINE MONOPHOSPHATE | 1 |
| Kmetal | POTASSIUM ION | 1 |
| MGmetal | MAGNESIUM ION | 1 |
| VMX | 5'-{[(3-aminopropyl)sulfonyl]amino}-5'-deoxyadenosine | 1 |